Expression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycle

被引:26
作者
Möller, B [1 ]
Lindblom, B [1 ]
Olovsson, M [1 ]
机构
[1] Uppsala Univ, Dept Womens & Childrens Hlth, SE-75185 Uppsala, Sweden
关键词
angiogenesis; endometrium; VEGF-B; VEGF-C; VEGF receptors;
D O I
10.1034/j.1600-0412.2002.810903.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. Endometrial angiogenesis is important for bleeding control and fertility, and is believed to be regulated by angiogenic growth factors under the influence of ovarian steroids. Objective. To document the pattern of expression of the two angiogenic growth factors, vascular endothelial growth factor (VEGF)-B and VEGF-C, and of their receptors, VEGFR-1, VEGFR-2, and VEGFR-3, in order to investigate their possible role in the regulation of angiogenesis in normal cycling human endometrium. Material and methods. Cryosections of endometrial biopsy specimens obtained from 17 healthy women before laparoscopic sterilization were examined by immunohistochemistry. Results. Vascular endothelial growth factor and VEGF-C and their receptors were all expressed in and around endometrial blood vessels, with no obvious menstrual cycle-dependent changes in expression except for VEGFR-2, which showed stronger expression during the early secretary phase. Stromal blood vessel density did not change significantly during the menstrual cycle. Conclusion. The presence and pattern of expression of these angiogenic growth factors and their receptors suggest that they participate in the regulation of normal endometrial angiogenesis.
引用
收藏
页码:817 / 824
页数:8
相关论文
共 37 条
[1]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[2]   Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia [J].
Bellomo, D ;
Headrick, JP ;
Silins, GU ;
Paterson, CA ;
Thomas, PS ;
Gartside, M ;
Mould, A ;
Cahill, MM ;
Tonks, ID ;
Grimmond, SM ;
Townson, S ;
Wells, C ;
Little, M ;
Cummings, MC ;
Hayward, NK ;
Kay, GF .
CIRCULATION RESEARCH, 2000, 86 (02) :E29-E35
[3]   Vascular endothelial growth factor C induces angiogenesis in vivo [J].
Cao, YH ;
Linden, P ;
Farnebo, J ;
Cao, RH ;
Eriksson, A ;
Kumar, V ;
Qi, JH ;
Claesson-Welsh, L ;
Alitalo, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) :14389-14394
[4]   Genomic organization of human and mouse genes for vascular endothelial growth factor C [J].
Chilov, D ;
Kukk, E ;
Taira, S ;
Jeltsch, M ;
Kaukonen, J ;
Palotie, A ;
Joukov, V ;
Alitalo, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25176-25183
[5]  
DAMJANOV I, 1986, LAB INVEST, V55, P588
[6]   Cardiovascular failure in mouse embryos deficient in VEGF receptor-3 [J].
Dumont, DJ ;
Jussila, L ;
Taipale, J ;
Lymboussaki, A ;
Mustonen, T ;
Pajusola, K ;
Breitman, M ;
Alitalo, K .
SCIENCE, 1998, 282 (5390) :946-949
[7]  
Eichmann A, 1998, DEVELOPMENT, V125, P743
[8]   Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia [J].
Enholm, B ;
Paavonen, K ;
Ristimaki, A ;
Kumar, V ;
Gunji, Y ;
Klefstrom, J ;
Kivinen, L ;
Laiho, M ;
Olofsson, B ;
Joukov, V ;
Eriksson, U ;
Alitalo, K .
ONCOGENE, 1997, 14 (20) :2475-2483
[9]  
Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1
[10]  
Fong GH, 1999, DEVELOPMENT, V126, P3015